By contrast, triple-negative breast cancer (TNBC) lacks these three receptors (estrogen receptor (ER), progesterone receptor (PR), and HER2) and, thus, is a diagnosis of exclusion showing the basal subtype in molecular profiling. The gene discussed is ESR1; the disease is triple-negative breast carcinoma.